🇲🇹

Malta for Biotech / Life Sciences

europeRemittance-BasedBIOTECH / LIFE SCIENCES
72
Overall
61
BIOTECH
Industry Rank
#12of 27
Key Strength
Family
Tax Regime
Remittance-Based
Verdict
Best For

Founders relocating with family - Malta scores 100/100 on cost of living, safety, and international schooling.

Not Ideal For

Founders whose top priority is minimising corporate tax - Malta's corporate tax score (25/100) is not a standout advantage.

Bottom Line

Ranked #12 of 27 jurisdictions for Biotech / Life Sciences. The Biotech / Life Sciences weighting reduces Malta's score by 11 points from its overall score of 72/100 - general strengths don't fully translate to this specific industry.

BIOTECH / LIFE SCIENCES-WEIGHTED DIMENSION PROFILE

Muted: default profile / Blue: industry-weighted

Strengths
Family100

Strong family environment for biotech / life sciences operators.

Visa90

Strong visa environment for biotech / life sciences operators.

Practical86

Strong practical environment for biotech / life sciences operators.

Watch Outs
Tax25

Lower tax score - verify current requirements carefully.

Ecosystem50

Lower ecosystem score - verify current requirements carefully.

Tax Res.70

Lower tax res. score - verify current requirements carefully.

Key Metrics for Biotech / Life Sciences
35%
Corporate Tax
18
Active VCs
$120M
VC Deployed
Yes
Gov Grants
Yes
EU Funding
55
Talent Pool
Yes
IP Box Regime
7
Incorporation

Why Malta Works for Biotech / Life Sciences

Family viability (100/100) is a genuine strength for Malta - important for Biotech / Life Sciences founders relocating with a partner or children. The cost of living index is 72 (NYC = 100), with a comfortable family monthly budget of $6K. Safety scores 72/100. International schools are available, and healthcare quality scores 74/100 with private insurance running approximately $250/month.

Operational ease (86/100) makes Malta practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated moderate. Company formation takes approximately 7 days at a cost of around $2K, with annual compliance costs around $3K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated moderate, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.

Funding access (85/100) is a standout for Malta Biotech / Life Sciences companies. The local market has 18 active VC funds, with average seed checks of $400K. Government grant programs include Malta Enterprise R&D Grant ($200K) and ERDF/ESF EU Funds ($500K). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.

Watch Outs for Biotech / Life Sciences Founders in Malta

Corporate tax (25/100): Tax efficiency is not the primary reason to choose Malta for Biotech / Life Sciences operations. Founders whose primary goal is minimising the corporate tax line should model effective rates carefully and compare against jurisdictions with zero or near-zero corporate tax.

Ecosystem depth (50/100): The local startup ecosystem is less developed than leading hubs. Biotech / Life Sciences founders who depend on domain-specific mentors, accelerators, or local angel networks may find the community thinner than in Europe or Singapore. Remote-first operations and access to global networks can compensate, but this is a real consideration for companies that benefit from in-person founder density.

Setup Requirements for Biotech / Life Sciences in Malta
  1. Entity type: 100% foreign-owned company permitted - no local partner required
  2. Banking: moderate access for foreign founders. Common options include Bank of Valletta, HSBC Malta, APS Bank.
  3. Formation: approximately 7 days to incorporate, estimated cost $2K plus annual compliance of $3K
  4. Licensing: Regulator - Medicines Authority / EMA
  5. Timeline: 60 days visa processing + 7 days formation = approximately 67 days to be fully operational
  6. Visa pathway: Startup Residence Programme (minimum investment $27K, 12-month initial permit)
Industry Key Facts
Medicines Authority / EMA
Regulator
Limited (500K population)
Trial Scale
Patent box regime available
IP Box
IP holding rather than operations
Use Case
Compare Malta vs Top Alternatives for Biotech / Life Sciences
🇲🇹Malta
61
🇨🇾Cyprus
65

Biotech / Life Sciences industry scores

🇲🇹Malta
61
🇮🇪Ireland
52

Biotech / Life Sciences industry scores

🇲🇹Malta
61
🇵🇹Portugal
66

Biotech / Life Sciences industry scores

Top Biotech / Life Sciences Jurisdictions
Frequently Asked Questions
Is Malta good for Biotech / Life Sciences in 2026?

Malta ranks #12 of 27 jurisdictions for Biotech / Life Sciences on NomadSignal's scoring model, with an industry-weighted score of 61/100. The top strengths for Biotech / Life Sciences founders are family viability and operational ease. Whether it is the right choice depends on your funding stage, personal tax situation, and whether you are relocating alone or with a family.

What is the corporate tax rate in Malta?

Malta applies a statutory corporate tax rate of 35%, and an IP box regime at 0% for qualifying IP income. The jurisdiction has 77 active tax treaties. For Biotech / Life Sciences founders, corporate tax efficiency carries a 8% weight in the industry scoring model. Verify the current effective rate with a local advisor before making an incorporation decision.

Does Malta have Biotech / Life Sciences-specific programs or incentives?

Malta Medicines Authority handles drug approval with EMA linkage. Small patient population limits trial scale. Malta is primarily a holding/IP jurisdiction for biotech rather than a clinical development base. Patent protection follows EU standards. Malta offers a startup or entrepreneur visa pathway for qualifying founders. NomadSignal evaluates Biotech / Life Sciences-specific factors including Regulatory Approval Pathway, Clinical Trial Environment, Patent Regime for Biologics as part of the industry score. Check the country's official government and innovation agency websites for current program details.

How does Malta compare to other jurisdictions for Biotech / Life Sciences?

Malta ranks #12 for Biotech / Life Sciences with 61/100. The #1 ranked jurisdiction is Singapore at 73/100. The gap is driven mainly by corporate tax, where Malta is weaker. Use NomadSignal's comparison pages to evaluate Malta head-to-head against specific alternatives.

Discussion (0)

A community of sovereign individuals - founders, families, and remote operators. Share what you know, ask what you don't.

No comments yet - be the first to share what you know about this page.

Data as of March 2026. Not legal, tax, or immigration advice.